AlgenAir

Living Technology—removing C02 more efficiently with the power of algae

Print
Follow Claim My Business
Security Type
Crowd SAFE
Min Investment
$150
Location
PITTSBURGH, PA
Offering Date
August 16, 2022
Expected Close Date
January 31, 2023
Target Raise
$25.00K-$1.24M
No. Investors
51
Security Price
$1
Website
algenair.com
Number of Employees
2
Cash
$34,380
Revenue
$39,758
Short Term Debt
$5,924
Cost of Goods
$25,197
Long Term Debt
$125,000
Net Income
$-104,534

Company Description

CO2 and VOCs accumulate indoors. This is known as sick building syndrome, or SBS. And what that means for you is...

Perks

Reserve
$200
Receive
AlgenAir Sticker

Reserve
$500
Receive
AlgenAir T-shirt

Reserve
$1,000
Receive
50% off the aerium

Reserve
$2,500
Receive
aerium + algae refill kit

Reserve
$5,000
Receive
aerium + 1 year refill subscription

Reserve
$10,000
Receive
Zoom Call with Founders
Limited (10 left of 10)

Reserve
$75,000
Receive
Custom large scale installation
Limited (3 left of 3)

Key Deal Facts

Living technology that uses algae to remove CO2 and VOCs from indoor air
The aerium is the first consumer natural air purifier that uses algae
25x more efficient than your average house plants to reduce CO2
Manufactured in the United States
Hardware with high retention recurring revenue subscription model
Fresh-grown spirulina is recycled as a supplement, fertilizer, or compost
Expanding into commercial space with pilot launching Summer 2022

Management Team / Advisory Board Bios

Kelsey Abernathy
Co-Founder & CEO

Dan Fucich
Co-founder & CSO
Amount Raised : $34,770
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments